CD44 and neoplasm: We have previously identified a unique subpopulation with CSCs properties in HNSCC using surface markers CD44 and CD133 (CD44+CD133+ defined as CSCs) and demonstrated its robust self-renewal and tumor-initiating potentials both in vitro and in vivo23.